SCHEMBL514736

SCHEMBL514736

CCCC=CCCCCCCCCC

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.67
TRPV1 Q8NER1 1/20 0.67
TERT O14746 3/20 0.56
PTPN1 P18031 3/20 0.56
PPARG P37231 3/20 0.56
PPARD Q03181 3/20 0.56
PPARA Q07869 3/20 0.56
CYP1A2 P05177 2/20 0.56
MAPT P10636 2/20 0.56
CYP2C19 P33261 2/20 0.56
BLM P54132 2/20 0.56
HSD17B10 Q99714 2/20 0.56
FABP4 P15090 2/20 0.56
KMT2A Q03164 2/20 0.56
TOP1 P11387 2/20 0.56
GMNN O75496 1/20 0.56
USP2 O75604 1/20 0.56
LMNA P02545 1/20 0.56
POLB P06746 1/20 0.56
CYP2C9 P11712 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2837920 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL454819 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL454818 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5854348 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5854970 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL2357077 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5855889 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5855886 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL20584432 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5853539 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4687854-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY Flagship Labs 114, Inc. (US) 2026-02-11 EP claimed
WO-2024211865-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY OMEGA THERAPEUTICS, INC. (US) 2024-10-10 WO claimed
CN-111051314-B Process for preparing bicyclic enol ethers 弗门尼舍有限公司 2023-10-27 CN claimed
CN-113166167-A Process for preparing bicycloalkenol ethers 弗门尼舍有限公司 2021-07-23 CN claimed
EP-3649134-A1 PROCESS FOR PREPARING BICYCLIC ENOLETHER Firmenich SA (CH) 2020-05-13 EP claimed
CN-111051314-A Process for preparing bicycloalkenol ethers 弗门尼舍有限公司 2020-04-21 CN claimed
CN-111013201-A Defoaming agent composition 江苏四新科技应用研究所股份有限公司 2020-04-17 CN claimed
US-3992453-A Hydroformylation process UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-11-16 US claimed
US-3969413-A Hydroformylation process using catalyst comprising cobalt and polynitroaryl compounds UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-07-13 US claimed
US-3959386-A Production of primary compounds UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-05-25 US claimed
EP-3856879-B1 BASE STOCKS AND OIL COMPOSITIONS CONTAINING THE SAME EXXONMOBIL CHEMICAL PATENTS INC (US) 2026-03-25 EP disclosed
US-12570592-B2 Higher secondary alcohol alkoxylate precursor, higher secondary alcohol alkoxylate adduct and higher secondary alkyl ether sulfate ester salt, and methods for producing these NIPPON SHOKUBAI CO., LTD. (JP) 2026-03-10 US disclosed
WO-2026043843-A1 TETRAHYDROPYRIMIDINE (THP) IONIZABLE LIPIDS FOR EFFICIENT MRNA DELIVERY THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, (US) 2026-02-26 WO disclosed
EP-4687854-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY Flagship Labs 114, Inc. (US) 2026-02-11 EP disclosed
CN-120202196-A Substitution as fungicides benzodiazepines of (C) 巴斯夫欧洲公司 2025-06-24 CN disclosed
US-4009203-A REACTION PRODUCT OF TIN HALIDE WITH A CARBOXYLIC ACID AS CATALYST UNIVERSAL OIL PRODUCTS COMPANY (US) 1977-02-22 US disclosed
US-3992423-A Production of carboxylic acids from olefins with a zeolite in aluminum hydrosol catalysts UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-11-16 US disclosed
US-3992453-A Hydroformylation process UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-11-16 US disclosed
US-3969413-A Hydroformylation process using catalyst comprising cobalt and polynitroaryl compounds UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-07-13 US disclosed
US-3950385-A Preparation of nitronitrates TEXACO INC. (US) 1976-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570592-B2 Higher secondary alcohol alkoxylate precursor, higher secondary alcohol alkoxylate adduct and higher secondary alkyl ether sulfate ester salt, and methods for producing these ADH1A, ADH5, ADH1C FAAH 760/4885TRPV1 2603/4885TERT 154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.